MedTrace Logo

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

NCT00353483 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-11-28

No results posted yet for this study

Summary

The main purpose of this study is to compare genetic markers present on tumor cells before and after chemotherapy.

Conditions

  • Breast Neoplasms

Interventions

PROCEDURE

Peripheral blood draw

PROCEDURE

Breast tissue collection

PROCEDURE

Bone marrow biopsy

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Rebecca Aft, M.D., Ph.D. · Washington University School of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-14
Primary Completion
2026-08-31
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00353483 on ClinicalTrials.gov